Trexquant Investment LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1633445 STAMFORD, CT

Position in TBPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,299,973

-$2,039,901 QoQ

Shares Held

76,469

-62.8% QoQ

Ownership

0.147%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#50

of 179 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. TBPH ranks #98 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	TWST	Twist Bioscience Corp	255,271	$26,262,280
3	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
4	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
5	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
6	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
7	INSM	INSMED Inc	156,553	$16,691,680
8	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,299,973	76,469	-62.8%	Shares	Sole	2026-08-14
2026-03-31	$3,339,874	205,784	+12.8%	Shares	Sole	2026-05-15
2025-12-31	$3,414,387	182,490	+26.3%	Shares	Sole	2026-02-17
2025-09-30	$2,110,181	144,533	-7.9%	Shares	Sole	2025-11-14
2025-06-30	$1,730,937	156,930	-5.1%	Shares	Sole	2025-08-12
2025-03-31	$1,477,236	165,424	+9.5%	Shares	Sole	2025-05-14
2024-12-31	$1,421,691	151,083	+50.7%	Shares	Sole	2025-02-12
2024-09-30	$808,071	100,257	+199.1%	Shares	Sole	2024-11-12
2024-06-30	$284,266	33,522	+79.2%	Shares	Sole	2024-08-13
2022-12-31	$209,870	18,705	-9.8%	Shares	Sole	2023-02-13
2021-12-31	$229,055	20,729	+57.4%	Shares	Sole	2022-02-14
2020-09-30	$194,674	13,167	+18.3%	Shares	Sole	2020-11-06
2020-06-30	$233,534	11,126	—	Shares	Sole	2020-08-07
No filing history on record for this holder in this stock.